Barnes & Noble Shares Soar After Investor Discusses Sale with Founder
07 Sep, 2018
CVS Health Corp. (NYSE:CVS) reported its third quarter earnings and beat analysts’ estimates, but shares fell by over 3 percent early shortly after open on Monday.For the third quarter, CVS reported revenue of $46.18 billion, increasing 3.5 pe..
Novartis AG (NYSE: NVS) has entered into a written agreement with French pharmaceutical company, Advanced Accelerator Applications (NASDAQ: AAAP), for $3.9 billion. Novartis shares were up 0.8 percent and Advanced Accelerator Applications shares wer..
On Wednesday, Abbott Laboratories (NYSE: ABT) announced its financial results for the third quarter of 2017, with both earnings and revenue beating estimates. Shares of the company increased 1.6% in morning trade on Wednesday.According to the compan..
Spectrum Pharmaceutical Inc. (NASDAQ: SPPI) shares surged over 40 percent on Tuesday at open after its announcement of positive results from its Phase 2 clinical study of poziotinib. The announcement was presented at the 18th IASLC World Conference ..
On Tuesday, Johnson & Johnson (NYSE: JNJ) announced its financial results for the third quarter of 2017. The company also adjusted its guidance for full-year 2017 in the statement on Tuesday.For the third quarter of 2017, the company announced s..
The National Institutes of Health and 11 biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT). This is a five-year-public-private research collaboration totaling $215 million as part of the Cancer Moons..
On Tuesday, Pfizer Inc. (NYSE: PFE), the pharmaceutical giant, said that it is considering the sale or spin-off of its consumer healthcare business, whose brands include lip balm Chapstick and painkiller Advil.The company’s consumer healthcare..
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).